Frosinone, Italy

Agnese Paesano


Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1991-1995

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Agnese Paesano: Innovator in Pharmaceutical Chemistry

Introduction

Agnese Paesano is a prominent inventor based in Frosinone, Italy. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. Her work focuses on developing innovative compounds with therapeutic applications.

Latest Patents

One of her latest patents involves the creation of 8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives. This invention describes these compounds and their salts, which exhibit adenosine antagonist activity. The patent also outlines a process for preparing these compounds and pharmaceutical compositions that can be used as antidepressants, nootropics, and psychostimulant drugs. Another notable patent is for 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(RS)-substituted. This invention details new compounds with antioxidizing and radical-scavenging properties, along with their synthesis and therapeutic uses.

Career Highlights

Agnese Paesano is currently associated with Biomedica Foscama Industria Chimicofarmaceutica S.p.a., where she continues to advance her research in pharmaceutical innovations. Her work has been instrumental in developing new drugs that address various health issues.

Collaborations

Throughout her career, Agnese has collaborated with notable colleagues, including Mario Brufani and Romolo Scuri. These partnerships have contributed to her success in the field and have fostered a collaborative environment for innovation.

Conclusion

Agnese Paesano is a trailblazer in pharmaceutical chemistry, with a focus on developing innovative compounds for therapeutic use. Her contributions through her patents and collaborations highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…